TABLE III.
Characteristic | Pts (n) | E-Cadherin | p Value | Vimentin | p Value | ||
---|---|---|---|---|---|---|---|
|
|
||||||
Positive | Negative | Positive | Negative | ||||
Differentiation | 1.000 | 0.263 | |||||
Poorly | 24 | 19 | 5 | 12 | 12 | ||
Well or moderately | 34 | 27 | 7 | 22 | 12 | ||
No information | 22 | 17 | 5 | 12 | 10 | ||
| |||||||
TNM stage | 0.052 | 0.007 | |||||
I–II | 22 | 21 | 1 | 18 | 4 | ||
III–IV | 58 | 42 | 16 | 28 | 30 | ||
| |||||||
Sex | 0.584 | 0.364 | |||||
Men | 33 | 25 | 8 | 17 | 16 | ||
Women | 47 | 38 | 9 | 29 | 18 | ||
| |||||||
Age group | 0.066 | 0.892 | |||||
≤61 Years | 44 | 38 | 6 | 25 | 19 | ||
>61 Years | 36 | 25 | 11 | 21 | 15 | ||
| |||||||
Smoking status | 0.981 | 0.286 | |||||
Yes | 21 | 16 | 5 | 10 | 11 | ||
No | 59 | 47 | 12 | 36 | 23 | ||
| |||||||
Driving gene mutation | 0.312 | 0.155 | |||||
EGFR | 43 | 32 | 11 | 25 | 18 | ||
ALK | 5 | 3 | 2 | 1 | 4 | ||
EGFR and ALK | 2 | 2 | 0 | 2 | 0 | ||
Wild type | 30 | 26 | 4 | 18 | 12 |
Pts = patients.